Nanoco (LSE:NANO) reported full-year trading in line with expectations, as licensing income supported revenue and the company’s streamlined operating structure helped deliver earnings and cash slightly ahead of market forecasts.
Unaudited revenue for the year reached £11.3 million, with the majority generated from licence income and a further £1.5 million coming from non-licence activities. Underlying adjusted EBITDA was £6.1 million, while year-end cash stood at £9.3 million, with both measures marginally exceeding expectations.
The company’s recent reorganisation has also significantly reduced its operating cost base. Gross monthly cash costs are now running at between £0.3 million and £0.4 million, providing Nanoco with a leaner structure as it focuses resources on licensing, material development and commercial partnerships.
Operational progress continues with Nanoco’s first Asian chemical customer under a three-year joint development agreement. The company remains on schedule to complete all milestones planned for the first year of the programme and expects material volumes associated with the relationship to more than double during FY27, albeit from a relatively modest initial level.
Nanoco is also extending development activities with a second Asian partner and remains in discussions with additional prospective customers. Much of this commercial activity is focused on sensing applications, an area the company views as an important opportunity for its proprietary nanomaterials technology.
Alongside these commercial initiatives, Nanoco is continuing the shareholder consultation process launched in late June. Feedback from investors, together with progress across its Asian partnerships, could influence the company’s strategic direction and the development of future commercial agreements.
The latest developments reflect Nanoco’s evolution towards a more focused, licence-led and partnership-driven business model. A reduced cost structure, recurring licensing income and expanding development relationships could provide greater visibility over medium-term opportunities as the company seeks to convert technical programmes into larger material supply arrangements.
Nanoco’s wider investment outlook nevertheless remains constrained by underlying financial weaknesses, including negative profitability, deteriorating operating cash flow and negative equity on the balance sheet. Technical indicators are also unfavourable, with the shares trading below all major moving averages. A very low price-to-earnings multiple provides some valuation support, although this is tempered by the limited confirmation from the company’s broader fundamentals.
More About Nanoco Group plc
Nanoco Group plc is a London-listed developer and manufacturer of cadmium-free quantum dots and other advanced nanomaterials based on its proprietary technology platform.
The company works with major chemical businesses and other commercial partners to develop materials for specialised applications, with its current business development efforts particularly focused on opportunities within sensing markets.
Following its recent restructuring, Nanoco operates with a substantially reduced cost base and is increasingly centred on licensing, collaborative development programmes and potential material supply agreements.
Relationships with Asian chemical companies form an important part of this strategy, with Nanoco seeking to increase material volumes as development programmes mature and to secure additional partnerships capable of generating longer-term commercial revenue.
Leave a Reply